Press Releases

NEW YORK, Feb. 10, 2020 /PRNewswire/ -- The Alzheimer's Foundation of America (AFA) has launched a new chat feature through its Alzheimer's Helpline that allows licensed social workers to provide assistance and support to families affected by Alzheimer's disease and other dementia-related illnesses in 90 different languages. 

BIRMINGHAM, Ala., Feb. 10, 2020 /PRNewswire/ -- Shegun Otulana, CEO of Therapy Brands, announced today that Kimberly O'Loughlin will succeed him as CEO of the company, effective February 10. Therapy Brands is a leading provider of mental, behavioral and rehabilitation health soft

BOTHELL, Wash. and TOKYO, Feb. 10, 2020 /PRNewswire/ -- Seattle Genetics, Inc. (Nasdaq: SGEN) and

NEWPORT BEACH, Calif., Feb. 10, 2020 /PRNewswire/ -- Hoag's Jeffrey M. Carlton Heart & Vascular Institute recently expanded its ability to manage and treat complex aortic pathology with the launch of the

RARITAN, N.J., Feb. 10, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of DARZALEX® (daratumumab) in combination with Kyprolis® (carfilzomib) and dexam

KING OF PRUSSIA, Pa., Feb. 10, 2020 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its fourth quarter and full year ended December 31, 2019 after the market closes on Wednesday, February 26, 2020.  There will be a conference call for investors an

SAN DIEGO, Feb. 10, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for its third quarter ended December 31, 2019 and provided an update on recent developments.

RESTON, Va., Feb. 10, 2020 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology leader, announced today the formation of a Scientific Advisory Board (SAB) for its

CARMIEL, Israel, Feb. 10, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, announced today that one

AUSTIN, Texas, Feb. 10, 2020 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced results for its fourth quarter and full-year ended December 31, 2019. All amounts in this release are in conformity with U.S. generally accepted accounting principles ("GAAP").CURRENT HIGHLIGHTS